EVC
LLY icon

Eidelman Virant Capital’s Eli Lilly LLY Stock Holding History

Eidelman Virant Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$464K Sell
1,425
-250
-15% -$79.2K 0.34% 83
2022
Q2 		$538K Hold
1,675
– – 0.39% 77
2022
Q1 		$479K Sell
1,675
-2,000
-54% -$515K 0.26% 93
2021
Q4 		$1.02M Buy
+3,675
New +$932K 0.37% 67

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Eidelman Virant Capital's LLY Position: Q3 2022 in Review

Eidelman Virant Capital reduced its Eli Lilly (LLY) stake by 15% in Q3 2022, selling an estimated $79.2K and leaving 1,425 shares worth $464K. The position accounts for 0.34% of the portfolio, ranked #83.

Eidelman Virant Capital first reported a position in LLY in Q4 2021 and has held it in 4 quarters since. The position peaked at $1.02M in Q4 2021. 2,484 funds tracked by Wall St. Rank hold LLY as of Q3 2022.

  • Eidelman Virant Capital held 1,425 shares of Eli Lilly worth $464K as of Q3 2022.
  • Eidelman Virant Capital sold 250 Eli Lilly shares in Q3 2022, an estimated $79.2K.
  • Eli Lilly made up 0.34% of Eidelman Virant Capital's portfolio in Q3 2022, its #83 holding.
  • Eidelman Virant Capital first reported a position in Eli Lilly in Q4 2021 and has held it in 4 quarters since.
  • Eidelman Virant Capital's Eli Lilly position peaked at $1.02M in Q4 2021.
  • 2,484 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2022.

Based on Eidelman Virant Capital's 13F filing for Q3 2022, filed 25 Oct 2022.